AgeX shareholders approve Juvenescence proposal allowing increased stake via preferred conversion

Serina Therapeutics, Inc.

Juvenescence proposal approved: 18,908,391 for, 7,461,795 against, 38,095 abstain; 4.8M broker non-votes.
Three directors re-elected: Bailey (18.6M for), Hackett (18.9M), Renondin (19.7M); broker non-votes 4.8M each.
Auditor WithumSmith+Brown ratified: 23.5M for, 7.3M against, 496,875 abstain.
Meeting held Dec 13, 2023; 82.36% of 37.95M shares represented.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Serina Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accountants at the 2023-12-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-12-13

Exact text from the filing

The appointment of WithumSmith + Brown PC as our independent registered public accountants for the fiscal year ending December 31, 2023 was ratified by the following vote: Shares Voted For 23,460,256 Against 7,298,688 Abstain 496,875

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Serina Therapeutics, Inc. shareholders approved Proposal to permit Juvenescence Limited to acquire additional shares through conversion of Series B Preferred Stock at the 2023-12-13 meeting.

Outcome: passed
Meeting: 2023-12-13

Exact text from the filing

The Juvenescence was approved by the following vote: Shares Voted For 18,908,391 Against 7,461,795 Abstain 38,095

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Serina Therapeutics, Inc. shareholders approved Election of three directors at the 2023-12-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-12-13

Exact text from the filing

Each of the following nominees were elected as directors by the following vote: Nominee Votes For Votes Withheld Gregory Bailey 18,629,281 7,779,000 Joanne Hackett 18,946,164 7,462,117 Jean-Christophe Renondin 19,707,041 6,701,172

View on SEC.gov

462 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-045275

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.